The year-long medical isotope shortage contributed to reduced revenue for nuclear medicine firm Digirad of Poway, CA, in the third quarter (end-September 30).
Total revenue decreased to $13.3 million, down 21% from $16.9 million in the third quarter of 2009. The company also posted a net loss of $1.3 million, compared with a net loss of $400,000 in the same quarter of 2009.
For the nine-month period, total revenue was $41.5 million, down 22% from $53.2 million for the first nine months of 2009. Digirad posted a net loss of $5.7 million during this period, compared with net income of $400,000 in the first nine months of 2009, the company said.
Related Reading
Digirad taps West Physics Consulting, May 24, 2010
Digirad gets FDA nod for camera, April 27, 2010
Digirad's revenues slip in Q3, October 23, 2009
Digirad releases c.pax software, October 19, 2009
Digirad posts Q2 profit as sales dip, July 24, 2009
Copyright © 2010 AuntMinnie.com
